9/23/2019 · Acceda automáticamente al gráfico en tiempo real de las acciones de Cytori Therapeutics (PSTV) de Investing.com. El gráfico es intuitivo y potente, ofreciendo a los usuarios varios tipos de gráfico, incluyendo el de velas, área, líneas, barras y Heiken Ashi. [2019-04-22] Cotización en bolsa de Cytori Therapeutics Inc. Series S Warrant (CYTXZ): 0.0011$ (-72.5%) - Aprende Day Trading de una forma sencilla con profesionales.

9/23/2019 · Acceda automáticamente al gráfico en tiempo real de las acciones de Cytori Therapeutics (PSTV) de Investing.com. El gráfico es intuitivo y potente, ofreciendo a los usuarios varios tipos de gráfico, incluyendo el de velas, área, líneas, barras y Heiken Ashi. [2019-04-22] Cotización en bolsa de Cytori Therapeutics Inc. Series S Warrant (CYTXZ): 0.0011$ (-72.5%) - Aprende Day Trading de una forma sencilla con profesionales. {{ menus.user.data_crypt.username }} {{item.text}} Acceder Cotización de CYTORI THERAPEUTICS: Acciones e información {{ menus.user.data_crypt.username }} Reciba gratis sus datos actualizados y en vivo para Cytori Therapeutics Inc - Cotización, gráficos, precios, análisis, noticias y pronósticos para CYTX. ¡Entrar Esta página contiene las Noticias más recientes sobre las acciones de Cytori Therapeutics Inc.

Infórmese de primera mano sobre las cotizaciones de las acciones de la empresa CYTORI THERAPEUTICS. Histórico, últimas noticias, evolución y dividendos.

Discover Company Info on Cytori Therapeutics Inc in New Jersey, such as Contacts, Addresses, Reviews, and Registered Agent. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Cytori Therapeutics, Inc. Cytori Therapeutics, Inc . (NASDAQ:CYTX) announced today that the US Food and Drug Administration (FDA) Division of Industry and Consumer Education (DICE) has granted Small Business status to Cytori Therapeutics for Fiscal Year 2017. John Ferris Formerly Senior Director - European Business Development at Cytori Therapeutics Darlington, United Kingdom Medical Devices 14 people have recommended John 5/31/2017 · SAN DIEGO, May 31, 2017 -- Cytori Therapeutics, Inc. today announced that the Company and the Biomedical Advanced Research and Development Authority , a 4/1/1998 · Descubre precios históricos de las acciones de SRPT en Yahoo Finanzas. Consulta informes diarios, semanales o mensuales desde la fecha de emisión de las acciones de Sarepta Therapeutics, Inc. hasta el presente. 5/31/2017 · On May 26, 2017, Cytori Therapeutics, Inc., a Delaware corporation (the “Company”) received notice from the Biomedical Advanced Research and Development Authority (“BARDA”), a division of the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, that BARDA had agreed to an

Valor Precio Valores Gráfica Histórico Ganancias Rentabilidad Por Dividendo - CYTX Cytori Therapeutics Requisitos De Dividendos Ordinarios - 12/23/2019.

We are driven by the pursuit of safe and effective medical devices that improve the health and well-being of people. 16 Jul 2019 Plus Therapeutics Reflects A New Focus On Developing Innovative Drugs. 30 May 2019 SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) today announced that it convened its annual 

Análisis técnico de CYTORI THERAPEUTICS Reciba en su email: Noticias de fondos, últimas horas, análisis técnicos o el cierre de mercado.

5/3/2019 · Información financiera sobre las acciones de Cytori Therapeutics (PSTV), incluyendo precio de las acciones, último cierre, volumen, variación en 1 año, rango intradía, rango de 52 semanas, capitalización bursátil, ingresos, dividendo etc. de PSTV. 9/23/2019 · Acceda a la información más detallada en el gráfico avanzado sobre las acciones Cytori Therapeutics (PSTV) de Investing.com.

Cytori Therapeutics Inc (NASDAQ: CYTX) subió un 8,7% el miércoles. La compañía cotizó tan alto como $ 0.25 y la última cotización fue de $ 0.25. Aproximadamente 5,413 acciones cambiaron de manos durante las operaciones del mediodía, una disminución del 99% respecto al volumen promedio diario de 474,979 acciones.

6/2/2017 · SAN DIEGO, Feb. 06, 2017 -- Cytori Therapeutics, Inc. announced today that the US Food and Drug Administration Division of Industry and Consumer Valor Precio Valores Gráfica Histórico Ganancias Rentabilidad Por Dividendo - CYTX Cytori Therapeutics El Costo De Ventas - 11/20/2019. In the U.S. our goal is to bring our cell therapy to market for treatment of chronic ischemic heart failure through Cytori-sponsored clinical development efforts and to develop a treatment for thermal burns combined with radiation injury under a contract from BARDA, a division of the U.S. Department of Health and Human Services. 9/19/2016 · Cytori Therapeutics Inc (NASDAQ:CYTX) announced that the Company and Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services, increased the contract option originally signed in August 2014 to fund continued investigation and development of Cytori Cell Therapy™ for use in The U.S. Food and Drug Administration (FDA) has granted Cytori Therapeutics Small Business status designation for fiscal year 2017, meaning that the company will pay reduced fees for regulatory filings that may arise from initiatives like the Phase 3 trial of its Habeo Cell Therapy for hand dysfunction and Raynaud’s phenomenon associated with

30 May 2019 SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) today announced that it convened its annual  Get today's Plus Therapeutics Inc stock price and latest PSTV news as well as Cytori Therapeutics real-time stock quotes, technical analysis, full financials and